Posted by sadsuzie on November 19, 2001, at 21:03:50
This is probably old news to most of you, but I thought I'd post it in case anyone is interested.
Somerset Announces Submission of New Drug Application For EMSAM(TM) (Selegiline Transdermal System)
5/25/2001 6:40:24 AM (PRNewswire) -- TAMPA, Fla.,Somerset Pharmaceuticals, Inc.("Somerset"), which is owned 50% by Watson Pharmaceuticals, Inc. (NYSE: WPI) and 50% by Mylan Laboratories, Inc. (NYSE: MYL) today announces the filing of a New Drug Application (NDA) with the United States Food and Drug Administration for registration of its EMSAM(TM) (Selegiline TransdermalSystem) 20mg/20cm2, for the treatment of depression.
poster:sadsuzie
thread:84719
URL: http://www.dr-bob.org/babble/20011113/msgs/84719.html